Reflecting their post-thymic origin, malignant clones in PTCL frequently express CD5, with studies reporting positivity in ~63% of cases, though there is notable variation in expression patterns between subtypes [129]. This evidence concerns the gene CD5 and mature T-cell and NK-cell non-Hodgkin lymphoma.